Mercedes Gonzalez-Juarrero Selected Research

Mercedes Gonzalez-Juarrero Research Topics

Disease

25	Infections 03/2024 - 12/2002
25	Tuberculosis (Tuberculoses) 03/2024 - 12/2002
5	Granuloma 06/2023 - 06/2005
3	Pulmonary Tuberculosis 01/2016 - 12/2002
3	Pneumonia (Pneumonitis) 07/2010 - 08/2005
2	Extensively Drug-Resistant Tuberculosis 11/2023 - 02/2014
2	Cystic Fibrosis (Mucoviscidosis) 01/2023 - 01/2020
2	Inflammation (Inflammations) 01/2023 - 07/2010
2	Lung Diseases (Lung Disease) 01/2020 - 07/2010
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018 - 01/2016
2	Foreign Bodies (Foreign Body) 09/2015 - 07/2009
1	Communicable Diseases (Infectious Diseases) 11/2023
1	Hypoxia (Hypoxemia) 01/2022
1	COVID-19 04/2021
1	Infertility (Sterility) 01/2019
1	Necrosis 06/2015
1	Leprosy (Hansen's Disease) 12/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2014
1	Weight Gain 04/2014
1	Melioidosis 12/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2012
1	Disease Progression 10/2008
1	Persistent Infection 10/2008

Drug/Important Bio-Agent (IBA)

10	AerosolsIBA 11/2023 - 04/2006
5	VaccinesIBA 12/2022 - 11/2007
5	CytokinesIBA 01/2018 - 12/2002
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 02/2014
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2014 - 06/2005
3	Spectinomycin (Spectinomycin Hydrochloride)FDA Link 01/2023 - 02/2014
3	Interleukin-10 (Interleukin 10)IBA 03/2009 - 12/2002
2	Polysaccharides (Glycans)IBA 03/2024 - 01/2023
2	lipoarabinomannan (LAM)IBA 03/2024 - 01/2023
2	spectinamide 1599IBA 06/2023 - 01/2023
2	Tigecycline (Tygacil)FDA Link 01/2023 - 01/2020
2	Oxygen (Dioxygen)IBA 01/2022 - 11/2011
2	Biocompatible Materials (Biomaterials)IBA 09/2015 - 07/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 04/2006
1	Biomarkers (Surrogate Marker)IBA 03/2024
1	Linezolid (Zyvox)FDA Link 11/2023
1	bedaquiline (R207910)IBA 11/2023
1	pretomanidIBA 11/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	PowdersIBA 01/2023
1	Mannose (D-Mannose)IBA 01/2023
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2022
1	Clofazimine (Lamprene)FDA Link 01/2022
1	Excipients (Suspending Agents)IBA 04/2021
1	Lipid NanoparticlesIBA 04/2021
1	Vitamin K 2 (Vitamin K2)IBA 10/2020
1	Oxidoreductases (Dehydrogenase)IBA 10/2020
1	Mutant Proteins (Protein, Mutant)IBA 10/2020
1	BCG Vaccine FDA Link 01/2020
1	Antitubercular AgentsIBA 01/2019
1	Methanol (Carbinol)IBA 01/2019
1	Peptides (Polypeptides)IBA 11/2018
1	MitogensIBA 08/2018
1	benzothiazoleIBA 01/2018
1	AmidesIBA 01/2018
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 08/2014
1	Bacterial Proteins (Bacterial Protein)IBA 02/2014
1	Capreomycin (Capastat)FDA Link 07/2012
1	Isoniazid (Ftivazide)FDA LinkGeneric 07/2012
1	Amikacin (A.M.K)FDA LinkGeneric 07/2012
1	Butylated Hydroxytoluene (BHT)IBA 07/2010
1	Interleukin-4 (Interleukin 4)IBA 07/2010
1	ArginaseIBA 07/2010
1	Macrophage Colony-Stimulating FactorIBA 04/2008
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2005
1	DNA (Deoxyribonucleic Acid)IBA 08/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2002
1	Interleukin-2 (IL2)IBA 12/2002

Therapy/Procedure

7	Therapeutics 07/2022 - 02/2012
3	Drug Therapy (Chemotherapy) 01/2018 - 12/2014
1	RNAi Therapeutics 01/2016